
Drug Manufacturing
- Kemio follows a blend of manufacturing strategies to optimise capacity and contain costs, and allow the customers to utilize appropriate plants for different manufacturing requirements
- Modern lab equipment to allow rapid scale-up up to 2kg within the facility.
- For larger scale-up, Kemio utilizes NIPER and Fleming Labs.
- The partnership with Fleming labs is an invested approach to service manufacturing needs of customers. Kemio Solutions has been given mandate to access the 100KL cGMP / USFDA inspected facility to manufacture API’s / Intermediates under appropriate confidentiality coverage and its own supervision.
- Kemio has successfully scaled up and delivered multiple challenging projects to big pharma with zero quality defects and has established a successful track record in this domain.